전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved13 programs
CGTLimited DatastaleAbbViePhase 2

Granulocyte Colony-Stimulating Factor (Granulocyte Colony-Stimulating Factor)

AML, Childhood; Aml · AML, Childhood

#AMLChildhood#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 32Status Recruiting
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 19Status Active
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

Icrucumab (Icrucumab)

Colon Cancer; Rectal Cancer · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#monoclonal-antibody#ColonCancer+2
Trials 4Status Active
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#monoclonal-antibody#Non-SmallCellLungCancer+1
Trials 2Status Active
AntibodyLimited DatastaleKing Faisal Specialist Hospital…Preclinical

Capecitabine (Xelodaâ, Capecitabine, Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®))

Colon Rectal Cancer Duke Stage Stageval · Colon Rectal Cancer Duke Stage Stageval

#ColonRectalCancerDukeStageStagev#Antibody#Preclinical#monoclonal-antibody#King
Trials 1Status Active
AntibodyLimited DatastaleNeovii BiotechPhase 3

Removab (Catumaxomab, Catumaxomab (Removab))

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast); Malignant Ascites · EpCam Positive Tumor (e.g.Ovarian, Gastr

#EpCamPositiveTumoregOvarianGastr#Antibody#Phase3#monoclonal-antibody#EpCamPositiveTumoregOvarian+3
Trials 1Status Active
CGTLimited DatastaleThe Affiliated Hospital of Qing…Preclinical

Chimeric antigen receptor T cell preparation targeting GCC (Chimeric antigen receptor T cell preparation targeting GCC)

Colon Cancer · Colon Cancer

#ColonCancer#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleQilu Hospital of Shandong Unive…Preclinical

Doublet or triplet chemotherapy combined with cetuximab (Doublet or triplet chemotherapy combined with cetuximab)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Preclinical#monoclonal-antibody#Qilu
Trials 1Status Active
AntibodyLimited DatastaleMassachusetts General HospitalPhase 3

Encorafenib/Binimetinib/Cetuximab Protocol (Encorafenib/Binimetinib/Cetuximab Protocol)

Metastatic Colon Cancer; Stage III Colon Cancer · Metastatic Colon Cancer

#MetastaticColonCancer#Antibody#Phase3#monoclonal-antibody#StageIIIColonCancer+1
Trials 1Status Recruiting
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 1

Expanded CB-NK cells (Expanded CB-NK cells)

Colon Cancer; Resected Stage · Colon Cancer

#ColonCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
ADCLimited DatastaleGilead SciencesPhase 2

LG (Labetuzumab Govitecan, Labetuzumab Govitecan (LG))

Metastatic Colorectal Cancer; Colon Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#antibody-drug-conjugate#ColonCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 1

Peri operative Cetuximab. (Peri operative Cetuximab.)

Colon Cancer · Colon Cancer

#ColonCancer#Antibody#Phase1#monoclonal-antibody#Eli
Trials 1Status Discontinued
AntibodyLimited DatastaleDaping Hospital and the Researc…Phase 2

PCSK9 Inhibitor (Tolecizumab, Tolecizumab (PCSK9 Inhibitor))

Colon Adenocarcinoma · Colon Adenocarcinoma

#ColonAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#Daping
Trials 1Status Recruiting